Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Tekmira Pharmaceuticals
Tekmira Pharmaceuticals
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Tekmira to suspend Ebola drug development
Will change name to Arbutus Biopharma and focus on developing treatments for hepatitis B
Research & Development
Tekmira Pharmaceuticals in multiyear agreement with Bristol-Myers Squibb
Transaction includes US$3m upfront payment to Tekmira
Research & Development
A silent revolution
Increased understanding of RNA interference has led to an explosion of gene silencing drug research projects. Dr Sarah Houlton reviews the progress being made in recent drug trials and looks at the remaining challenges
Research & Development
Tekmira and Pfizer agree research collaboration
They will evaluate SNALP technology to deliver small interfering RNA (siRNA) molecules
Subscribe now